Other studies showed that TRIM24 is overexpressed in acute promyelocytic leukemia and papillary thyroid carcinomas, respectively, and is a chromosomal translocation target of Braf (T18) and Ret oncogenes [18], [26], [27]. This evidence concerns the gene RET and differentiated thyroid carcinoma.